{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:50:17Z","timestamp":1791273017171,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016042"],"award-info":[{"award-number":["P30CA016042"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["689715"],"award-info":[{"award-number":["689715"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-173496"],"award-info":[{"award-number":["PJT-173496"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["23573"],"award-info":[{"award-number":["23573"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP340674"],"award-info":[{"award-number":["MOP340674"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Airc Italian Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000241","name":"Physicians' Services Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ebiom.2022.104373","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T16:13:10Z","timestamp":1669392790000},"page":"104373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification"],"prefix":"10.1016","volume":"86","author":[{"given":"Peter Y.F.","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Shammas-Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"De Cecco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara S.","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1294-6859","authenticated-orcid":false,"given":"Stefano","family":"Cavalieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Licitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hoebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud H.","family":"Brakenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ren\u00e9","family":"Leemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Scheckenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8968-1409","authenticated-orcid":false,"given":"Tito","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Laxague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7201-6181","authenticated-orcid":false,"given":"Eitan","family":"Prisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Poh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinaki","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Dort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushfiq H.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.B.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-1324","authenticated-orcid":false,"given":"Mohammed I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Howlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Stecho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Plantinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Daniela da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halema","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"MacNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pencilla","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Winquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedyeh","family":"Ziai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L.","family":"Amelio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn S-C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe S.","family":"Mymryk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-980X","authenticated-orcid":false,"given":"Anthony C.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2022.104373_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105177","article-title":"Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: a systematic review of population-based studies","volume":"115","author":"Menezes","year":"2021","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ebiom.2022.104373_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","article-title":"The changing therapeutic landscape of head and neck cancer","volume":"16","author":"Cramer","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"29","key":"10.1016\/j.ebiom.2022.104373_bib4","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104373_bib5","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1158\/1078-0432.CCR-09-3185","article-title":"Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer","volume":"16","author":"Nichols","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104373_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3747\/co.20.1375","article-title":"The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian population","volume":"20","author":"Nichols","year":"2013","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123443","article-title":"Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status","volume":"4","author":"Ghasemi","year":"2019","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104373_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3757","article-title":"Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas","volume":"49","author":"Papillon-Cavanagh","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2022.104373_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.oraloncology.2018.12.010","article-title":"Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients","volume":"89","author":"Teft","year":"2019","journal-title":"Oral Oncol"},{"issue":"36","key":"10.1016\/j.ebiom.2022.104373_bib10","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1200\/JCO.2017.73.8633","article-title":"Radiation therapy for oropharyngeal squamous cell carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline","volume":"35","author":"Quon","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104373_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.6004\/jnccn.2020.0031","article-title":"Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Pfister","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104373_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"O'Sullivan","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ebiom.2022.104373_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2016.09.006","article-title":"Treatment de-intensification strategies for head and neck cancer","volume":"68","author":"Kelly","year":"2016","journal-title":"Eur J Cancer"},{"issue":"40","key":"10.1016\/j.ebiom.2022.104373_bib14","first-page":"1","article-title":"Novel strategies to effectively de-escalate curative-intent therapy for patients with HPV-associated oropharyngeal cancer: current and future directions","volume":"40","author":"Price","year":"2020","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104373_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2022.0615","article-title":"Assessment of toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma: the ORATOR2 phase 2 randomized clinical trial","volume":"8","author":"Palma","year":"2022","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104373_bib16","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1470-2045(19)30410-3","article-title":"Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial","volume":"20","author":"Nichols","year":"2019","journal-title":"Lancet Oncol"},{"issue":"0","key":"10.1016\/j.ebiom.2022.104373_bib17","first-page":"JCO2101961","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial","volume":"0","author":"Nichols","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104373_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jamaoncol.2017.0973","article-title":"Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques","volume":"3","author":"Leeman","year":"2017","journal-title":"JAMA Oncol"},{"issue":"10166","key":"10.1016\/j.ebiom.2022.104373_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"issue":"10166","key":"10.1016\/j.ebiom.2022.104373_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ebiom.2022.104373_bib21","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.19.00441","article-title":"Role of treatment deintensification in the management of p16+ oropharyngeal cancer: ASCO provisional clinical opinion","volume":"37","author":"Adelstein","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"22","key":"10.1016\/j.ebiom.2022.104373_bib22","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.20.00056","article-title":"De-escalation after DE-ESCALATE and RTOG 1016: a head and neck cancer InterGroup framework for future de-escalation studies","volume":"38","author":"Mehanna","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.ebiom.2022.104373_bib23","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1200\/JCO.21.00594","article-title":"Treatment de-intensification for HPV-positive oropharynx cancer: what is currently acceptable?","volume":"39","author":"Cmelak","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"36","key":"10.1016\/j.ebiom.2022.104373_bib24","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2016.72.0748","article-title":"Development and validation of nomograms predictive of overall and progression-free survival in patients with oropharyngeal cancer","volume":"35","author":"Fakhry","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"22","key":"10.1016\/j.ebiom.2022.104373_bib25","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.19.00463","article-title":"Phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human papillomavirus-associated oropharynx squamous cell carcinoma","volume":"37","author":"Ma","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104373_bib26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104373_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/jamaoncol.2016.1790","article-title":"The molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platform","volume":"3","author":"Morris","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijrobp.2016.04.027","article-title":"Strategy of using intratreatment hypoxia imaging to selectively and safely guide radiation dose de-escalation concurrent with chemotherapy for locoregionally advanced human papillomavirus-related oropharyngeal carcinoma","volume":"96","author":"Lee","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18","key":"10.1016\/j.ebiom.2022.104373_bib29","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-16-0323","article-title":"Subtypes of HPV-positive head and neck cancers are associated with HPV characteristics, copy number alterations, PIK3CA mutation, and pathway signatures","volume":"22","author":"Zhang","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/cancers12010253","article-title":"Survival-associated metabolic genes in human papillomavirus-positive head and neck cancers","volume":"12","author":"Prusinkiewicz","year":"2020","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104373_bib31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/ng.3051","article-title":"Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss","volume":"46","author":"Gross","year":"2014","journal-title":"Nat Genet"},{"issue":"21","key":"10.1016\/j.ebiom.2022.104373_bib32","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.3390\/cancers13215313","article-title":"3p arm loss and survival in head and neck cancer: an analysis of TCGA dataset","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ebiom.2022.104373_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104944","article-title":"Chromosome 3p loss in the progression and prognosis of head and neck cancer","volume":"109","author":"Shaikh","year":"2020","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124762","article-title":"Variations in HPV function are associated with survival in squamous cell carcinoma","volume":"4","author":"Gleber-Netto","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104373_bib35","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"issue":"7536","key":"10.1016\/j.ebiom.2022.104373_bib36","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104373_bib37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ijc.33849","article-title":"Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma","volume":"150","author":"Liu","year":"2022","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104373_bib38","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1200\/PO.21.00094","article-title":"Clinical validity of a prognostic gene expression cluster-based model in human papillomavirus\u2013positive oropharyngeal carcinoma","author":"Cavalieri","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ebiom.2022.104373_bib39","article-title":"Prognostic value and cost benefit of HPV testing for oropharyngeal cancer patients","author":"Lu","year":"2021","journal-title":"Oral Dis"},{"issue":"23","key":"10.1016\/j.ebiom.2022.104373_bib40","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1158\/0008-5472.CAN-17-0833","article-title":"Integrated analysis of whole-genome ChIP-seq and RNA-seq data of primary head and neck tumor samples associates HPV integration sites with open chromatin marks","volume":"77","author":"Kelley","year":"2017","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104373_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PLoS Med"},{"issue":"9596","key":"10.1016\/j.ebiom.2022.104373_bib42","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41199-019-0045-0","article-title":"Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival","volume":"4","author":"Mundi","year":"2019","journal-title":"Cancers Head Neck"},{"issue":"40","key":"10.1016\/j.ebiom.2022.104373_bib44","doi-asserted-by":"crossref","first-page":"26064","DOI":"10.18632\/oncotarget.25436","article-title":"High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines","volume":"9","author":"Ghasemi","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104373_bib46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104373_bib47","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104373_bib48","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/bioinformatics\/bty037","article-title":"HPViewer: sensitive and specific genotyping of human papillomavirus in metagenomic DNA","volume":"34","author":"Hao","year":"2018","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"issue":"14","key":"10.1016\/j.ebiom.2022.104373_bib50","doi-asserted-by":"crossref","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Sturm","year":"2019","journal-title":"Bioinformatics"},{"issue":"18","key":"10.1016\/j.ebiom.2022.104373_bib51","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"issue":"7791","key":"10.1016\/j.ebiom.2022.104373_bib52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B\u00a0cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104373_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ccell.2020.12.007","article-title":"Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma","volume":"39","author":"Huang","year":"2021","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104373_bib54","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/hed.24889","article-title":"Primary treatment for oropharyngeal squamous cell carcinoma in Alberta, Canada: a population-based study","volume":"39","author":"Hobbs","year":"2017","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.0006-341X.2001.00114.x","article-title":"A\u00a0solution to the problem of monotone likelihood in Cox regression","volume":"57","author":"Heinze","year":"2001","journal-title":"Biometrics"},{"issue":"7414","key":"10.1016\/j.ebiom.2022.104373_bib57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"10135","key":"10.1016\/j.ebiom.2022.104373_bib58","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib59","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","article-title":"Immune landscape of viral- and carcinogen-driven head and neck cancer","volume":"52","author":"Cillo","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104373_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1535293","article-title":"Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma","volume":"8","author":"Lechner","year":"2019","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104373_bib61","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/jamaoncol.2016.4500","article-title":"Immune response to HPV16 E6 and E7 proteins and patient outcomes in head and neck cancer","volume":"3","author":"Nelson","year":"2017","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104373_bib62","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djaa184","article-title":"Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial","volume":"113","author":"Riaz","year":"2021","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104373_bib63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10585-022-10148-9","article-title":"Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review","volume":"39","author":"Morand","year":"2022","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ijc.30046","article-title":"Change in CD3zeta-chain expression is an independent predictor of disease status in head and neck cancer patients","volume":"139","author":"Upreti","year":"2016","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104373_bib65","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ni764","article-title":"Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases","volume":"3","author":"Colucci","year":"2002","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104373_bib66","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ni1357","article-title":"Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination","volume":"7","author":"Klein","year":"2006","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104373_bib67","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/ni.3231","article-title":"T\u00a0cell receptor dwell times control the kinase activity of Zap70","volume":"16","author":"Klammt","year":"2015","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104373_bib68","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/ni1396","article-title":"RhoH GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development","volume":"7","author":"Gu","year":"2006","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104373_bib69","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.4049\/jimmunol.1701385","article-title":"Critical functions of IRF4 in B and T lymphocytes","volume":"199","author":"Hagman","year":"2017","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104373_bib70","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.4049\/jimmunol.175.10.6570","article-title":"Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages","volume":"175","author":"Lehtonen","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1158\/1078-0432.CCR-18-1749","article-title":"The anatomical location shapes the immune infiltrate in tumors of same etiology and affects survival","volume":"25","author":"Santegoets","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104373_bib72","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1498439","article-title":"Treatment-naive HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy","volume":"7","author":"Gameiro","year":"2018","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104373_bib73","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/v9090252","article-title":"Analysis of class I major histocompatibility complex gene transcription in human tumors caused by human papillomavirus infection","volume":"9","author":"Gameiro","year":"2017","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104373_bib74","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1541-7786.MCR-17-0153","article-title":"HPV integration in HNSCC correlates with survival outcomes, immune response signatures, and candidate drivers","volume":"16","author":"Koneva","year":"2018","journal-title":"Mol Cancer Res"},{"issue":"7875","key":"10.1016\/j.ebiom.2022.104373_bib75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","article-title":"Functional HPV-specific PD-1(+) stem-like CD8 T cells in head and neck cancer","volume":"597","author":"Eberhardt","year":"2021","journal-title":"Nature"},{"issue":"7875","key":"10.1016\/j.ebiom.2022.104373_bib76","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41586-020-2931-3","article-title":"Defining HPV-specific B cell responses in patients with head and neck cancer","volume":"597","author":"Wieland","year":"2021","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.ebiom.2022.104373_bib77","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1158\/1078-0432.CCR-20-4746","article-title":"Phase I\/Ib clinical trial of sabatolimab, an anti-TIM-3 antibody, alone and in combination with spartalizumab, an anti-PD-1 antibody, in advanced solid tumors","volume":"27","author":"Curigliano","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"8_suppl","key":"10.1016\/j.ebiom.2022.104373_bib78","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JCO.2019.37.8_suppl.12","article-title":"A\u00a0phase Ia\/Ib study of an anti-TIM-3 antibody (LY3321367) monotherapy or in combination with an anti-PD-L1 antibody (LY3300054): interim safety, efficacy, and pharmacokinetic findings in advanced cancers","volume":"37","author":"Harding","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"13","key":"10.1016\/j.ebiom.2022.104373_bib79","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1158\/1078-0432.CCR-19-3977","article-title":"Impact of neoadjuvant durvalumab with or without tremelimumab on CD8(+) tumor lymphocyte density, safety, and efficacy in patients with oropharynx cancer: CIAO trial results","volume":"26","author":"Ferrarotto","year":"2020","journal-title":"Clin Cancer Res"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422005552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422005552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:35:32Z","timestamp":1778873732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422005552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":79,"alternative-id":["S2352396422005552"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104373","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104373"}}